NDC 55111-467

Metoprolol succinate

Metoprolol Succinate

Metoprolol succinate is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is Metoprolol Succinate.

Product ID55111-467_bddedb83-ec1d-9ea4-7f13-3ba9250acd6f
NDC55111-467
Product TypeHuman Prescription Drug
Proprietary NameMetoprolol succinate
Generic NameMetoprolol Succinate
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2012-09-10
Marketing CategoryANDA / ANDA
Application NumberANDA090617
Labeler NameDr. Reddy's Laboratories Limited
Substance NameMETOPROLOL SUCCINATE
Active Ingredient Strength50 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55111-467-01

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-467-01)
Marketing Start Date2012-09-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-467-79 [55111046779]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-467-01 [55111046701]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-09-10

NDC 55111-467-60 [55111046760]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-467-78 [55111046778]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-467-30 [55111046730]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-467-05 [55111046705]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA090617
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-09-10

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL SUCCINATE50 mg/1

OpenFDA Data

SPL SET ID:90594d68-87f2-5f75-2d8a-1629f88ba8a9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866436
  • 866427
    • UPC Code
  • 0355111466017
  • 0355111467014

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    Medicade Reported Pricing

    55111046705 METOPROLOL SUCC ER 50 MG TAB

    Pricing Unit: EA | Drug Type:

    55111046701 METOPROLOL SUCC ER 50 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Metoprolol succinate" or generic name "Metoprolol Succinate"

    NDCBrand NameGeneric Name
    0378-4595Metoprolol Succinatemetoprolol succinate
    0378-4596Metoprolol Succinatemetoprolol succinate
    0378-4597Metoprolol Succinatemetoprolol succinate
    0378-4598Metoprolol Succinatemetoprolol succinate
    0527-2600METOPROLOL SUCCINATEMetoprolol succinate
    0527-2601METOPROLOL SUCCINATEMetoprolol succinate
    0527-2602METOPROLOL SUCCINATEMetoprolol succinate
    0527-2603METOPROLOL SUCCINATEMetoprolol succinate
    0615-6589METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6597METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6598METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7530METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7823Metoprolol succinateMetoprolol succinate
    0615-7824Metoprolol succinateMetoprolol succinate
    0615-7825Metoprolol succinateMetoprolol succinate
    0615-8024METOPROLOL SUCCINATEMetoprolol succinate
    0615-8025METOPROLOL SUCCINATEMetoprolol succinate
    0904-6322Metoprolol succinateMetoprolol succinate
    0904-6323Metoprolol succinateMetoprolol succinate
    0904-6324Metoprolol succinateMetoprolol succinate
    68001-121Metoprolol succinateMetoprolol succinate
    68001-122Metoprolol succinateMetoprolol succinate
    68001-120Metoprolol succinateMetoprolol succinate
    68001-357Metoprolol SuccinateMetoprolol Succinate
    68001-358Metoprolol SuccinateMetoprolol Succinate
    68001-360Metoprolol SuccinateMetoprolol Succinate
    68001-119Metoprolol succinateMetoprolol succinate
    68001-356Metoprolol SuccinateMetoprolol Succinate
    68071-1913Metoprolol SuccinateMetoprolol Succinate
    68071-1922Metoprolol succinateMetoprolol succinate
    68071-1921Metoprolol succinateMetoprolol succinate
    68071-1923Metoprolol SuccinateMetoprolol Succinate
    68071-2191Metoprolol succinateMetoprolol succinate
    68071-4074Metoprolol SuccinateMetoprolol Succinate
    68071-4377Metoprolol SuccinateMetoprolol Succinate
    68071-4572Metoprolol SuccinateMetoprolol Succinate
    68071-4363Metoprolol SuccinateMetoprolol Succinate
    68071-4351Metoprolol SuccinateMetoprolol Succinate
    68084-666Metoprolol succinateMetoprolol succinate
    68084-659Metoprolol succinateMetoprolol succinate
    68084-673Metoprolol succinateMetoprolol succinate
    68151-1840Metoprolol succinateMetoprolol succinate
    68258-6019Metoprolol SuccinateMetoprolol Succinate
    68382-566metoprolol succinatemetoprolol succinate
    68382-567metoprolol succinatemetoprolol succinate
    68382-564metoprolol succinatemetoprolol succinate
    68382-565metoprolol succinatemetoprolol succinate
    68645-479Metoprolol succinateMetoprolol succinate
    68645-478Metoprolol succinateMetoprolol succinate
    68645-477Metoprolol succinateMetoprolol succinate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.